Jan 14, 2026
How do intensive lifestyle programs compare to FDA‑approved Alzheimer’s drugs in randomized trials for early symptomatic patients?
A randomized phase‑2 trial of an intensive, multimodal lifestyle intervention reported measurable improvements in cognition and function after 20 weeks among people with mild cognitive impairment (MCI...